usak escort elazig escort

952 / Quality and safety of care in oncology: UMaCA (Antiblastic Centralized IV Admixtures Unit) Project in Parma Hospital

ITALY
Classification of the PSP
Type of Patient Safety Practice Safe
 
Clinical Risk Management Practice (CRMP)
Related practices from PaSQ database
"Best fit" category of the reported practice
Implementation of Patient Safety initiatives / Activities
Other There is no specified text here
Topic of the reported practice
Clinical risk management
Aim and the benefit of the Patient Safety Practice
 
To Ensure appropriateness in the management of oncohematological treatments, thus improving on use of economic resources; to support clinicians in the management of anticancer drugs through a constant interaction between the professionals involved; to guarantee the safety of patients and workers exposed to the risk of contamination from dangerous drugs.
Description of the Patient Safety Practice
 
A fundamental condition for safe handling of anticancer drugs is to create a responsible awareness in all the people at risk on the correct handling of cytotoxic drugs and contaminated materials and the use of personal protection measures. To this end, specific training/information events were organized for the staff involved. Management of the therapeutic process through a computerized system allows: development of a database of the therapeutic schemes of molecules and related handling procedures required for treatments preparation; prescription and administration management, and traceability of the pathway through an optical reading of a barcode; registration of side effects and adverse reactions. Carrying out this project led to a re-organization of oncological treatment process.
The main objectives of the UMACA project are: Centralization of equipment and quality assurance of drugs; Risk reduction for health care professionals; control of risk to patients; Management of the therapy according to a standardized process, traced and controlled; Constant interaction of professionals involved in patient care to improve the quality of care; Rationalization of the economic impact of cancer therapies and the constant analysis of the appropriateness for the individual patient. The centralization project UMaCA launched in May 2008, ended with the recruitment of the Unit of Pediatric Oncology in December 2012, for a total of 30 operating units involved in the project Some results: Units enrolled: 30; Therapeutic schemes discussed, updated and shared by Doctors and Pharmacists and formalized in the computerized database: 795; Patients cared for: 2,082; Number of admissions: more than 14,451; Number of administered therapies: 52 158 (oncohaematological therapies and support, even in the context of experimental studies). http://buonepratiche.agenas.it/practicesdetail.aspx?id=4102
Attachment of relevant written information and/or photos, as appropriate
There is no specified text here
There is no specified text here
There is no specified text here
There is no specified text here
Effectiveness of the Patient Safety Practice
 
Degree of implementation of reported practice
Yes, fully
Level of implementation of reported practice
Institution level
Specific and measurable outcome for the reported practice were defined
Yes
A baseline measurement before implementation of the reported practice was obtained
Yes
A measurement after full implementation of the reported practice was obtained
Yes
Evaluation of a "positive" effect of the reported practice on Patient Safety
The evaluation showed improvements in Patient Safety outcomes
Type of before-and after evaluation
Both/mixed (qualitative and quantitative)
Enclosure of a reference or attachment in case of published evaluation's results
There is no specified text here
There is no specified text here
Health care context where the Patient Safety Practices was implemented
 
Hospital
Transferability
 
Successful implementation of this Patient Safety Practice in other health care settings than above stated
Yes
Specification of implementation in another health care setting(s)
Community care facility
Successful implementation's level  of this Patient Safety Practice across settings
Yes, across multiple specialities within the same setting
Involved health care staff
 
Physicians
Nurses
Pharmacists
Quality manager
Risk manager
Patient Involvement
 
Direct service user's involvement as integral part of this Patient Safety Practice
No
Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice
There is no specified text here
Point of time in which service user or their reprasentatives' involvement takes place
There is no specified text here
Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice
There is no specified text here
Short description of the service users' level of involvement
There is no specified text here
Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users
Yes
List of sources where public information is accessible
http://buonepratiche.agenas.it/practicesedit.aspx?id=4102;
http://www.ao.pr.it/wpcontent/uploads/2013/10/2012_BILANCIO-DI-MISSIONE-con-segnalibri2.pdf
Implementation of the Patient Safety Practice
 
Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice
Yes
Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc.
Yes
List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice
Not sufficient human resources available
List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice
There is no specified text here
Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice
No
Description of used incentives, if any.
There is no specified text here
Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice
Yes
Costs of the Patient Safety Practices
 
Completion of cost calculation related to this Patient Safety Practice
No
Total number of person days required to implement this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total number of person days required for training as preparation for implementation of this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice
There is no specified text here
Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice
There is no specified text here
Contact information
 
Name: ALESSANDRA ZANARDI; GIOVANNA CAMPANIELLO
Country: ITALY
Organisation: Azienda Ospedaliero - Universitaria di Parma
E-mail: azanardi@ao.pr.it; gcampaniello@ao.pr.it
Phone: +39 0521702130; +39 0521703005
Print
Top
Anne Bebek cicicocuk Bebek, Çocuk, Genç
eos nedir